Skip to content
Home » Aaron Charlton

Aaron Charlton

FDA unproven drug

Pressure on the FDA to approve an unproven drug

In a pressure campaign to sway the FDA, advocates seek approval for an unproven drug to treat a rare genetic disorder. Despite public outcry, the FDA refused to greenlight the drug after it failed to demonstrate efficacy in a small-scale trial. It’s crucial to balance emotion with evidence in evaluating drug effectiveness. The FDA should not be swayed by public pressure to approve potentially unsafe drugs.